O Vuolteenaho
Overview
Explore the profile of O Vuolteenaho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
144
Citations
880
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karhu T, Akiyama K, Vuolteenaho O, Bergmann U, Naito T, Tatemoto K, et al.
Peptides
. 2017 Sep;
96:61-66.
PMID: 28867075
The human MAS-related G protein-coupled receptor X1 (MRGPRX1) is a member of the GPCR family. The receptor is primate specific and expressed in the sensory neurons of dorsal root ganglion...
2.
Karhu T, Akiyama K, Vuolteenaho O, Bergmann U, Naito T, Tatemoto K, et al.
Biochim Biophys Acta Gen Subj
. 2017 Aug;
1861(11 Pt A):2530-2534.
PMID: 28844982
Background: Mast cells are important modulators of the human immune system via their release of several inflammatory mediators and proteases. The release can be activated by different pathways: the classical...
3.
Kolto G, Vuolteenaho O, Szokodi I, Faludi R, Tornyos A, Ruskoaho H, et al.
Clin Exp Rheumatol
. 2014 Nov;
32(6 Suppl 86):S-75-81.
PMID: 25372791
Objectives: Cardiac involvement is an important determinant of prognosis in systemic sclerosis (SSc). The identification of patients with high risk is of great importance. Our aim was to investigate the...
4.
Karppinen S, Rapila R, Makikallio K, Hanninen S, Rysa J, Vuolteenaho O, et al.
Acta Physiol (Oxf)
. 2013 Dec;
210(2):369-80.
PMID: 24325624
Aim: Spontaneous activity of embryonic cardiomyocytes originates from sarcoplasmic reticulum (SR) Ca(2+) release during early cardiogenesis. However, the regulation of heart rate during embryonic development is still not clear. The...
5.
Partanen N, Husso M, Vuolteenaho O, Sipola P, Ruskoaho H, Peuhkurinen K, et al.
J Hum Hypertens
. 2011 Jan;
25(12):746-51.
PMID: 21248782
Early detection of left ventricular hypertrophy (LVH) is beneficial, since treatment-induced regression of LVH has been unequivocally associated with a better prognosis. Our aim was to study the relation of...
6.
Ola A, Kerkela R, Tokola H, Pikkarainen S, Skoumal R, Vuolteenaho O, et al.
Br J Pharmacol
. 2010 Jan;
159(3):717-25.
PMID: 20067472
Background And Purpose: The mixed-lineage kinases (MLKs) act upstream of mitogen-activated protein kinases, but their role in cardiac biology and pathology is largely unknown. Experimental Approach: We investigated the effect...
7.
Breuer T, Skoumal R, Horkay F, Merkely B, Ala-Kopsala M, Leppaluoto J, et al.
Acta Anaesthesiol Scand
. 2009 Nov;
54(4):502-9.
PMID: 19919584
Background: NT-proXNP, a new natriuretic peptide analyte, incorporates information about the concentrations of both N-terminal pro-atrial and pro-brain natriuretic peptides (NT-proANP, NT-proBNP). We aimed to investigate whether NT-proXNP is a...
8.
Majalahti T, Tokola H, Ruskoaho H, Vuolteenaho O
Mol Cell Endocrinol
. 2009 Jun;
307(1-2):50-6.
PMID: 19524126
Salmon cardiac natriuretic peptide (sCP, an A-type natriuretic peptide) is an excellent model for the study of cardiac chamber-specific gene expression because it is uniquely specific to the heart and...
9.
Kurl S, Ala-Kopsala M, Ruskoaho H, Makikallio T, Nyyssonen K, Vuolteenaho O, et al.
Heart
. 2009 Mar;
95(13):1067-71.
PMID: 19321489
Background: Risk stratification for cardiovascular outcomes is gaining importance in general population. Prognostic value of natriuretic peptides has been established in patients with heart failure. However, the prognostic significance of...
10.
Haggstrom J, Hansson K, Kvart C, Pedersen H, Vuolteenaho O, Olsson K
J Vet Cardiol
. 2008 Dec;
2(1):7-16.
PMID: 19081325
Objective: To study the responses of atrial natriuretic peptide (ANP), N-terminal fragment of pro-atrial natriuretic peptide (NT-proANP) and brain natriuretic peptide (BNP) to varying severity of mitral regurgitation (MR) in...